A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial
Objective: The objective was to evaluate the contraceptive effectiveness, safety, and acceptability of a novel vaginal pH regulator over seven cycles of use. Study design: A single-arm, open-label, phase 3 study was conducted across 112 sites in the United States in sexually active 18–35-year-old wo...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-01-01
|
| Series: | Contraception: X |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590151620300149 |